Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Ultomiris approved in Japan for aHUS in adults and children

Sep. 29, 2020

Dimerix reports phase II data on DMX-200 in diabetic kidney disease

Sep. 14, 2020

Bayer initiates enrollment in phase II CONCORD study of runcaciguat

Sep. 10, 2020

First subject dosed in phase I study of ALLN-346

Sep. 9, 2020

Akebia reports topline data from its PRO2TECT global phase III program of vadadustat

Sep. 4, 2020

Tohoku University divulges dioxolan derivatives for renal diseases

Sep. 2, 2020

Ardelyx divulges glycyrrhetinic derivatives for hyperkalemia

Sep. 1, 2020

Taisho Pharmaceutical discloses new 20-HETE synthase inhibitors

Aug. 31, 2020

Evotec and Novo Nordisk collaborate to develop novel therapies for CKD

Aug. 19, 2020

AstraZeneca is enrolling participants in phase I study of MEDI-8367

Aug. 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...